News

The Oral Medicine Services team at Fred Hutch Cancer Center addresses the complex oral health needs of patients undergoing ...
What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...
During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...
Dr. Hans-Peter Kiem is deputy director of the Translational Science and Therapeutics division at Fred Hutch. His specialty is gene therapy and stem cell engineering, specifically for blood cell ...
Seattle-based Fred Hutchinson Cancer Center’s sixth president, Thomas Lynch, MD, stepped into the role in February 2020, at the same time COVID-19 was beginning to transform the healthcare ...
Fred Hutchinson Cancer Center has agreed to pay about $11.5 million to patients after a 2023 cyberattack put their personal data at risk. Hackers targeted parts of Fred Hutch’s clinical network ...
Frederick R. Appelbaum, MD, recognized for advancing marrow transplantation, talks about the impact of canine research on ...
Valarie Traynham shares what survivorship means to her, and how the definition has evolved after her diagnosis, during National Cancer Survivors Month.
May 29—Fred Hutchinson Cancer Center has agreed to pay about $11.5 million to patients after a 2023 cyberattack put their personal data at risk. Hackers targeted parts of Fred Hutch's clinical ...